Department of Psychiatry

Project seeks to treat Alzheimer’s in people with Down syndrome

A joint project between the Vanderbilt Kennedy Center and the Vanderbilt Center for Cognitive Medicine will help deliver Alzheimer’s disease therapies and treatments to people with Down syndrome (DS). 

Brain circuits in schizophrenia

Vanderbilt psychiatrists are probing brain circuit hyperactivity implicated in schizophrenia, with the idea that normalizing the hyperactivity may improve cognitive processes.

The psychosis study team includes, from left, Neil Woodward, PhD, Maureen McHugo, PhD, Stephan Heckers, MD, MSc, Suzanne Avery, PhD, and Kristan Armstrong, PhD.

NIMH support bolsters early psychosis research efforts

The Department of Psychiatry and Behavioral Sciences has received an additional $4 million from the National Institute of Mental Health (NIMH) to study the evolution of hippocampal dysfunction in the early stage of psychosis.

Pawlikowski named president of Vanderbilt Psychiatric Hospital

Mary Pawlikowski, MA, MEd, interim vice president and chief operating officer for Vanderbilt Psychiatric Hospital (VPH), has been named as the hospital’s new president after having held the position of president on an interim basis since November 2020.

Resident’s opioid-related efforts become TMA priority

Leah Jesse, MD, a Psychiatry resident, successfully brought an anti-stigma resolution to the floor of the Tennessee Medical Association (TMA) House of Delegates meeting in May.

Webinars share strategies for integrating addiction and behavioral health into primary care practices

David Marcovitz, MD, assistant professor of Psychiatry and Behavioral Sciences and director of the Division of Addiction Psychiatry, shared strategies for integrating addiction and behavioral health into primary care practices during two recent webinars — one for Vanderbilt Health Affiliated Network (VHAN) and one for the TennCare Delivery System Transformation Conference.

1 2 3 4 9